Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2001

01-10-2001 | Case Report

Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Authors: Hisashi Sakamaki, Yoriko Sato, Shin-ichiro Mori, Kazuteru Ohashi, Shu Tanikawa, Hideki Akiyama, Tsuneo Sasaki, Kiyoshi Hiruma

Published in: International Journal of Hematology | Issue 3/2001

Login to get access
Metadata
Title
Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
Authors
Hisashi Sakamaki
Yoriko Sato
Shin-ichiro Mori
Kazuteru Ohashi
Shu Tanikawa
Hideki Akiyama
Tsuneo Sasaki
Kiyoshi Hiruma
Publication date
01-10-2001
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2001
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982072

Other articles of this Issue 3/2001

International Journal of Hematology 3/2001 Go to the issue

OriginalPaper

RUNX1/AML1: A Central Player in Hematopoiesis

Rapid Communication

CD7+ Near-Tetraploid Acute Myeloblastic Leukemia M2 With Double t(8;21)(q22;q22) Translocations and AML1/ETO Rearrangements Detected by Fluorescence In Situ Hybridization Analysis

Letter to the Editor

Severe Autoimmune Hemolitic Anemia as a Potentially Fatal Complication of EBV Infectious Mononucleosis

Case Report

Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells

Rapid Communication

Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells

Rapid Communication

A Simple Centrifugation Method for Harvesting Myeloblasts
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits